An engineered bacterium for synthesizing resveratrol using glucose as a substrate, its construction and application
By constructing an engineered strain using glucose as a substrate, expressing a specific enzyme system, and optimizing gene expression, the problem of insufficient resveratrol production was solved, achieving efficient biosynthesis with a yield of 12-13 g/L, supporting industrial production.
Patent Information
- Application Number
- CN202111386598.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-11-22
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-11-22
AI Technical Summary
Existing technologies are insufficient for the efficient biosynthesis of resveratrol using glucose as a substrate, resulting in insufficient yields and limiting the large-scale industrial production of resveratrol.
An engineered strain using glucose as a substrate was constructed. By expressing L-tyrosine ammonia-lyase, p-coumaroyl-CoA ligase, resveratrol synthase, DAHP synthase, and branching acid mutase, the reaction was catalyzed by enzyme coupling. Gene expression was regulated by the hp4d promoter, and the gene sequence was optimized to improve catalytic efficiency.
It significantly increased the yield of resveratrol to 12-13 g/L, provided a safe biotransformation method for resveratrol, and laid the foundation for industrial production.
Smart Images

Figure GDA0004993246960000111 
Figure HDA0003367281450000011 
Figure HDA0003367281450000012
Abstract
Description
Technical Field
[0001] This invention belongs to the field of biotechnology, and in particular relates to an engineered bacterium that biosynthesizes resveratrol using glucose as a substrate, its construction, and its application. Background Technology
[0002] Resveratrol, also known as stilbene triol, is a natural non-flavonoid polyphenolic compound extracted from plants, belonging to the stilbene class of compounds. Resveratrol exists in plants primarily in four forms: trans-resveratrol, cis-resveratrol, trans-resveratrol glycoside, and cis-resveratrol glycoside, with the trans form being the predominant form. Trans-resveratrol exhibits higher bioactivity than cis-resveratrol and is found in various plants such as Japanese knotweed, grapes, and peanuts. Grapes have the highest resveratrol content among all fruits. It is mainly found in the roots, stems, leaves, flowers, fruits, and seeds of plants, and is a phytoalexin produced by plants under stress. Resveratrol has many beneficial physiological effects. It can scavenge free radicals and inhibit lipid peroxidation and lipoprotein modification caused by reactive oxygen species, thereby protecting the cardiovascular system. Resveratrol also exhibits anticancer activity through mechanisms such as regulating transcription factors and controlling small RNA expression.
[0003] Resveratrol is a plant secondary metabolite. It has been shown to have regulatory effects in antioxidation, anti-inflammation, anti-cancer, estrogen production, neuroprotection, cardioprotection, anti-atherosclerosis, anti-aging, anti-diabetic, anti-osteoporosis, and weight loss, making it highly sought after and with broad application prospects in medicine, health products, and cosmetics. Studies have shown that resveratrol exerts anti-tumor effects through multiple mechanisms and targets, especially in recent years, demonstrating significant inhibitory effects on various tumor cells, including cell carcinoma, breast cancer, colon cancer, gastric cancer, and leukemia, making it a hot research topic. Yersinia lipolytica is an important industrial microbial strain, recognized as a food-grade safe microorganism. It has many advantages, including a determined genome sequence, strong genetic manipulation capabilities, a wide range of substrate utilization, and the ability to secrete large amounts of various metabolites. Currently, it is used in multiple fields. Here, we integrated genetically engineered strains of L-tyrosine ammonia-lyase, p-coumaryl-CoA ligase, and resveratrol synthase. Using the hp4d promoter, we expressed L-tyrosine ammonia-lyase, p-coumaryl-CoA ligase, resveratrol synthase, DAHP synthase, and branching acid mutase in Yersinia lipolytica, thereby increasing the yield of resveratrol products and providing support for the large-scale industrial production of resveratrol. Summary of the Invention
[0004] One objective of this invention is to provide an engineered bacterium for the biosynthesis of resveratrol from glucose, its construction, and its application. This engineered bacterium achieves the biosynthesis of resveratrol from glucose by expressing L-tyrosine ammonia-lyase, p-coumaroyl-CoA ligase, resveratrol synthase, DAHP synthase, and branching acid mutase.
[0005] The second objective of this invention is to provide a method for constructing an engineered microbial strain that synthesizes resveratrol using glucose as a substrate. This invention utilizes an enzyme coupling method to simultaneously catalyze three reaction systems: L-tyrosine is converted to p-coumaric acid under the catalysis of L-tyrosine ammonia-lyase; p-coumaryl-CoA ligase catalyzes the conversion of p-coumaric acid to p-coumaryl-CoA; and finally, resveratrol is produced under the resveratrol synthase system. Simultaneously, the feedback inhibition regulation genes DAHP synthase and branching acid mutase genes, which are overexpressed with tyrosine, are used to relieve substrate inhibition, thereby improving the efficiency of the catalytic reaction and significantly increasing the yield of resveratrol.
[0006] The third objective of this invention is to provide a biotransformation method for the biosynthesis of resveratrol using glucose as a substrate by an engineered strain of microorganisms that synthesizes resveratrol using glucose as a substrate.
[0007] In the aforementioned engineered bacteria, the method for overexpressing L-tyrosine ammonia-lyase, p-coumaryl-CoA ligase, resveratrol synthase, DAHP synthase, and cladose acid mutase involves placing all the L-tyrosine ammonia-lyase genes, p-coumaryl-CoA ligase genes, resveratrol synthase, DAHP synthase, and cladose acid mutase genes after the promoter of the expression plasmid, and initiating transcription via the hp4d promoter; the DAHP synthase and cladose acid mutase genes are expressed in the single-copy expression plasmid pINA1269; the L-tyrosine ammonia-lyase gene, p-coumaryl-CoA ligase gene, and resveratrol synthase are expressed in the multi-copy expression plasmids pINA1312 and pINA1292, preferably in expression plasmid pINA1292.
[0008] This invention provides an engineered bacterium that biosynthesizes resveratrol using glucose as a substrate. The engineered bacterium contains an L-tyrosine ammonia-lyase gene, a p-coumaryl-CoA ligase gene, a resveratrol synthase, and a DAHP synthase ARO4. K221L and cladoid mutase ARO7 G139S The genes, whose nucleotide sequences are shown in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3, SEQ ID No. 4 and SEQ ID No. 5, respectively, express L-tyrosine ammonia hydrolase, p-coumaroyl-CoA ligase, resveratrol synthase, DAHP synthase and branching acid mutase.
[0009] The L-tyrosine ammonia-lyase gene, p-coumaryl-CoA ligase gene, and resveratrol synthase are derived from heterologous enzymes. The L-tyrosine ammonia-lyase gene TAL is derived from Flavobacterium johnsoniae (FjTAL); the 4-coumaryl-CoA ligase gene 4CL1 is derived from Arabidopsis thaliana (At4CL1); the resveratrol synthase gene VST1 is derived from Vitis vinifera (VvVST1); and the DAHP synthase ARO4... K221L and cladoid mutase ARO7 G139S The gene originates from Yersinia lipolytica; among them, ARO4 K221L The ARO4 gene has a lysine mutation at position 221 replaced by a leucine; ARO7 G139S The glycine at position 139 of the ARO7 gene is mutated to serine.
[0010] The nucleotide sequences of the L-tyrosine ammonia hydrolase gene, p-coumaroyl-CoA ligase gene, resveratrol synthase, DAHP synthase, and branching acid mutase gene are codon-optimized sequences based on the codon preference of Yersinia lipolytica.
[0011] The method for constructing the engineered bacteria that synthesize resveratrol using glucose as a substrate includes the following steps:
[0012] (1) Linearize the vector using PCR technology or enzyme digestion method, and recover the linearized vector fragment.
[0013] The L-tyrosine ammonia-lyase gene, p-coumaroyl-CoA ligase gene, and resveratrol synthase gene were amplified by PCR using specific primers, and the target fragments were recovered.
[0014] (2) Using artificially synthesized YIARO4 K221L YIARO7 G139S Using the gene as a template, the fusion gene YIARO4 was amplified using overlap PCR. K221L -YIARO7 G139S After enzyme digestion and ligation, the recombinant plasmid YIARO4 was constructed. K221L -YIARO4 G139S ;
[0015] (3) The obtained plasmid-YIARO4 K221L -YIARO4 G139S After enzyme digestion and linearization, the strain was transformed into Yersinia lipophila Po1f, and positive transformants were selected to obtain the initial engineered strain.
[0016] (4) Using DNA ligase, the target fragment containing the gene encoding L-tyrosine ammonia hydrolase, p-coumaroyl coenzyme A ligase and resveratrol synthase is ligated with the linearized vector fragment and transformed to obtain recombinant expression vector-FjTAL, recombinant expression vector-At4CL1 and recombinant expression vector-VvVST1.
[0017] (5) The expression cassettes hp4d-At4CL1-XPR2 and hp4d-VvVST1-XPR2 were amplified using specific primers, and then ligated using overlap PCR to amplify the dual expression cassette hp4d-At4CL1-XPR2-hp4d-VvVST1-XPR2. The linearized plasmid-FjTAL was inserted through seamless cloning to finally obtain the recombinant plasmid-FjTAL-At4CL1-VvVST1.
[0018] (6) The obtained plasmid -FjTAL-At4CL1-VvVST1 was digested with restriction endonuclease NotⅠ, linearized, and then transformed into the initial engineered strain in step (3) using the LiAC transformation method. It was then spread on SC-Ura yeast auxotrophic medium and cultured at 30℃ until transformants grew. Several positive transformants were randomly selected to obtain an engineered strain that synthesizes resveratrol using glucose as a substrate.
[0019] The biotransformation method for resveratrol also falls within the scope of protection of this invention, including the following steps:
[0020] (1) The engineered bacteria that synthesize resveratrol using glucose as a substrate were cultured to obtain seed culture;
[0021] (2) The seed liquid is inoculated into a fermentation medium containing glucose as a substrate and fermented to biotransform and synthesize resveratrol.
[0022] According to the above scheme, the biotransformation time is 115-125 hours.
[0023] According to the above scheme, the yield of resveratrol synthesized by the above biotransformation method is 12-13 g / L.
[0024] According to the above scheme, the specific biotransformation method is as follows:
[0025] Engineered bacteria that synthesize resveratrol using glucose as a substrate were streaked onto YNB solid medium and cultured until single colonies grew. Single colonies were then picked and inoculated into YNB liquid medium to obtain the seed culture. 600 =10-12;
[0026] The seed culture was inoculated into a fermentation medium containing glucose as a substrate and fermented. Glucose was fed during the fermentation process.
[0027] According to the above scheme, the culture conditions for the seed liquid are 28-30℃ and 200-225rpm.
[0028] According to the above scheme, the fermentation medium composition is as follows: substrate glucose 8%, (NH4)2SO4 0.5%, KH2PO4 0.3%, MgSO4·7H2O 0.05%, trace metal solution 0.2%, vitamin solution 0.1%, and defoamer 204 0.05%.
[0029] According to the above scheme, the fermentation conditions are 28-30℃, 200-225rpm, and the initial pH is 5.9-6.2. During the fermentation process, a pH adjuster is added to regulate the pH of the system to 5.9-6.2. Specifically, every 4.5-5.5 hours, 5M KOH is added artificially to regulate the pH to 5.9-6.2.
[0030] According to the above plan, during the fermentation stage, add 18-22 g / L of glucose every 22-24 hours.
[0031] According to the above scheme, the YNB liquid culture medium is 20-80 g / L glucose and 6.7 g / L YNB, preferably 20-60 g / L glucose as carbon source and 6.7 g / L YNB.
[0032] Compared with the prior art, the present invention has the following beneficial effects:
[0033] This invention integrates genetically engineered strains containing L-tyrosine ammonia-lyase, p-coumaryl-CoA ligase, resveratrol synthase, DAHP synthase, and cladose acid mutase. By overexpressing these enzymes, the resveratrol content is significantly increased, providing a simple and effective method for the safe biotransformation of resveratrol. The biotransformation yield of resveratrol using this engineered strain reaches 12-13 g / L. Attached Figure Description
[0034] Figure 1 A schematic diagram illustrating the construction of the recombinant plasmid pINA1292-FjTAL-At4CL1-VvVST1, which expresses L-tyrosine ammonia hydrolase, 4-coumarin-coenzyme A ligase, and resveratrol synthase.
[0035] Figure 2 The recombinant plasmid pINA1269-YIARO4 expresses DAHP synthase and cladistic acid mutase. K221L -YIARO7G139S A schematic diagram of its construction. Detailed Implementation
[0036] Example 1: Expression of DAHP synthase (YIARO4) K221L ) and cladoid mutase (YIARO7) G139S Increase resveratrol production
[0037] 1.pINA1269-YIARO4 K221L -YIARO7 G139S plasmid construction
[0038] (1) Using artificially synthesized YIARO4 K221L Using genes as templates, primer YIARO4 was used. K221L -YIARO7 G139S -F1 and YIARO4 K221L -YIARO7 G139 -R1 was used for PCR amplification, and the amplification product was recovered to obtain YIARO4. K221L The target fragment, with a size of 1446 bp, is obtained using the primer YIARO4. K221L -YIARO7 G139S -F1 sequence 5'-CCCCACGTGATGCCGCCGAAAGTGGTGAT-3', primer YIARO4 K221L -YIARO7 G139S -R1 sequence 5'-CGGGGTACCTTTCTGCGCGCGCATGCTAT-3'.
[0039] (2) Using artificially synthesized YIARO7 G139S Using genes as templates, primer YIARO4 was used. K221L -YIARO7 G139S -F2 and YIARO4 K221L -YIARO7 G139S -R2 was used for PCR amplification, and the amplification product was recovered to obtain YIARO7. G139S The target fragment, with a size of 768 bp, is obtained using the primer YIARO4. K221L -YIARO7 G139S -F2 sequence 5'-CCCCACGTGATGGATTTTACCAAAGCGGATAC-3', primer YIARO4 K221L -YIARO7 G139S -R2 sequence 5'-CGGGGTACCTTCCAGGCGGCGCAGCAG-3'.
[0040] (3) Using the YIARO4 recovered above K221L YIARO7 G139S The target fragment is also used as a template, utilizing primer YIARO4. K221L -YIARO7 G139S -F1 and YIARO4 K221L -YIARO7 G139S -R2 was used for PCR amplification, and the amplification product was recovered to obtain YIARO4. K221L -YIARO7 G139S The fusion gene fragment has a size of 2214 bp.
[0041] (4) Using restriction endonucleases PmlI and KpnI to simultaneously inhibit YIARO4 K221L -YIARO7 G139S The recovered product was double-digested with pINA1269 plasmid DNA, and ligated to obtain the recombinant plasmid pINA1269-YIARO4. K221L -YIARO7 G139S .
[0042] 2. Construction of engineered Yersinia lipophila
[0043] The above plasmid pINA1269-YIARO4 K221L -YIARO7 G139S After being digested with the restriction endonuclease NotⅠ and linearized, the strain was transformed into Yersinia lipolyticis Po1f using the LiAC transformation method. The transformed strain was then plated onto SC-Leu yeast auxotrophic medium and cultured at 30°C until transformants grew. Positive transformants were selected to obtain the initial engineered strain 1.
[0044] Example 2: Construction method of pINA1312-FjTAL-At4CL1-VvVST1 plasmid
[0045] 1. Construction of pINA1312-FjTAL, pINA1312-At4CL and pINA1312-VvVST1 plasmids
[0046] (1) Using the artificially synthesized FjTAL gene as a template, PCR amplification was performed using primers FjTAL-F and FjTAL-R, and the target fragment FjTAL was recovered with a size of 1521 bp.
[0047] (2) Using the artificially synthesized At4CL1 gene as a template, PCR amplification was performed using primers At4CL1-F and At4CL1-R, and the target fragment At4CL was recovered, with a fragment size of 1620bp.
[0048] (3) Using the artificially synthesized VvVST1 gene as a template, PCR amplification was performed with primers VvVST1-F and VvVST1-R, and the target fragment VvVST1 was recovered with a size of 1179 bp.
[0049] (4) The recovered fragments and pINA1312 plasmid DNA were digested with PmlI and KpnI, respectively, and then ligated and transformed into Escherichia coli DH5α. The recombinant plasmids pINA1312-FjTAL, pINA1312-At4CL1, and pINA1312-VvVST1 were successfully obtained.
[0050] 2. Obtaining the double frame of expression fragment hp4d-4CL-XPR2-hp4d-STS-XPR2
[0051] (1) Using pINA1312-At4CL1 plasmid DNA as a template, PCR amplification was performed using primers Expression Cassette-F1 and R1, and the hp4d-At4CL1-XPR2 DNA fragment containing the At4CL1 gene was recovered.
[0052] (2) Using pINA1312-VvVST1 plasmid DNA as a template, PCR amplification was performed using primers Expression Cassette-F2 and R2, and the hp4d-VvVST1-XPR2 DNA fragment containing the VvVST1 gene was recovered.
[0053] (3) Using the above hp4d-At4CL1-XPR2 DNA fragment and hp4d-VvVST1-XPR2 DNA fragment as templates, PCR amplification was performed using primers Expression Cassette-F1 and R2. Three DNA fragments containing the At4CL1 and VvVST1 genes were recovered, namely: hp4d-At4CL1-XPR2-hp4d-VvVST1-XPR2.
[0054] 3. Construction of pINA1312-TAL-4CL-STS plasmid
[0055] (1) The pINA1312-FjTAL plasmid constructed above was digested with the restriction endonuclease ClaI, and the digestion product pINA1312-FjTAL was recovered.
[0056] (2) The enzyme digestion products were seamlessly ligated with the dual expression cassette fragment to obtain the recombinant plasmid: pINA1312-FjTA L-At4CL1-VvVST1.
[0057] 2. Construction and shake-flask fermentation of engineered Yersinia lipophila.
[0058] (1) The plasmid pINA1312-FjTAL-At4CL1-VvVST1 obtained in Example 2 was digested with restriction endonuclease NotⅠ, linearized, and then transformed into engineered strain 1 using the LiAC transformation method. It was then plated on SC-Ura yeast auxotrophic medium and cultured at 30°C until transformants grew. Ten positive transformants were randomly selected to obtain the initial engineered strain 2-11 that could produce resveratrol.
[0059] (2) The engineered bacteria 2-11 was streaked onto YPD solid medium and cultured until single colonies grew. Single colonies were picked and inoculated into YPD liquid medium, and cultured for 15 hours to obtain a seed culture. The seed culture medium was YPD medium: 20 g / L glucose as the carbon source, containing 10 g / L yeast extract and 20 g / L peptone. The culture conditions for the seed culture were 30℃ and 225 rpm. The OD of the seed culture was... 600 =10;
[0060] (4) Inoculate 2% of the seed culture into a shake flask containing 50mLYPD liquid medium and carry out shake flask fermentation culture;
[0061] (5) After culturing for 2 hours, 20 g / L of substrate glucose was added for biotransformation. After 120 hours of transformation, the yield of resveratrol was detected by high performance liquid chromatography (HPLC).
[0062] High performance liquid chromatography (HPLC) for the determination of resveratrol:
[0063] (1) Add 1 mL of methanol to 1 mL of the above conversion solution to dissolve the product and obtain the product solution;
[0064] (2) The product solution was centrifuged at 5000 rpm for 10 min, and the supernatant was collected;
[0065] (3) The supernatant is filtered through a 0.22 μm filter membrane into a brown liquid phase bottle to obtain the sample to be tested;
[0066] (4) The chromatographic conditions for high performance liquid chromatography are as follows: the chromatographic column is a C18 (250mm*4.6mm, 5μm) or equivalent chromatographic column, the mobile phase is 72wt% water and 28wt% acetonitrile, the flow rate is 1mL / min, the injection volume is 10μL, and the column temperature is 30℃.
[0067] (5) Based on the peak area of the resveratrol standard, the resveratrol content was finally calculated, and the results are shown in Table 1.
[0068] Example 3: Construction method of pINA1292-FjTAL-At4CL1-VvVST1 plasmid
[0069] 1. Construction of pINA1292-FjTAL, pINA1292-At4CL and pINA1292-VvVST1 plasmids
[0070] (5) Using the artificially synthesized FjTAL gene as a template, PCR amplification was performed using primers FjTAL-F and FjTAL-R, and the target fragment FjTAL was recovered, with a fragment size of 1521 bp.
[0071] (6) Using the artificially synthesized At4CL1 gene as a template, PCR amplification was performed using primers At4CL1-F and At4CL1-R, and the target fragment At4CL was recovered, with a fragment size of 1620bp.
[0072] (7) Using the artificially synthesized VvVST1 gene as a template, PCR amplification was performed with primers VvVST1-F and VvVST1-R, and the target fragment VvVST1 was recovered with a size of 1179 bp.
[0073] (8) The recovered fragments and pINA1292 plasmid DNA were digested with PmlI and KpnI, respectively, and then ligated and transformed into Escherichia coli DH5α. Three recombinant plasmids were successfully obtained: pINA1292-FjTAL, pINA1292-At4CL1, and pINA1292-VvVST1.
[0074] 2. Obtaining the double frame of expression fragment hp4d-4CL-XPR2-hp4d-STS-XPR2
[0075] (1) Using pINA1292-At4CL1 plasmid DNA as a template, PCR amplification was performed using primers Expression Cassette-F1 and R1, and the hp4d-At4CL1-XPR2 DNA fragment containing the At4CL1 gene was recovered.
[0076] (2) Using pINA1292-VvVST1 plasmid DNA as a template, PCR amplification was performed using primers Expression Cassette-F2 and R2, and the hp4d-VvVST1-XPR2 DNA fragment containing the VvVST1 gene was recovered.
[0077] (3) Using the above hp4d-At4CL1-XPR2 DNA fragment and hp4d-VvVST1-XPR2 DNA fragment as templates, PCR amplification was performed using primers Expression Cassette-F1 and R2. Three DNA fragments containing the At4CL1 and VvVST1 genes were recovered, namely: hp4d-At4CL1-XPR2-hp4d-VvVST1-XPR2.
[0078] 3. Construction of pINA1292-TAL-4CL-STS plasmid
[0079] (1) The pINA1292-FjTAL plasmid constructed above was digested with the restriction endonuclease SpeI, and the digestion product pINA1292-FjTAL was recovered.
[0080] (2) The enzyme digestion products were seamlessly ligated with the dual expression cassette fragment to obtain the recombinant plasmid: pINA1292-FjTA L-At4CL1-VvVST1.
[0081] 2. Construction and shake-flask fermentation of engineered Yersinia lipophila.
[0082] (1) The plasmid pINA1292-FjTAL-At4CL1-VvVST1 obtained in Example 3 was digested with restriction endonuclease NotⅠ, linearized, and then transformed into engineered strain 1 using the LiAC transformation method. It was then plated on SC-Ura yeast auxotrophic medium and cultured at 30°C until transformants grew. Ten positive transformants were randomly selected to obtain the initial engineered strain 12-21 that could produce resveratrol.
[0083] (2) The engineered strain 12-21 was streaked onto YPD solid medium and cultured until single colonies grew. Single colonies were picked and inoculated into YPD liquid medium and cultured for 15 hours to obtain a seed culture. The seed culture medium was YPD medium: 20 g / L glucose as the carbon source, containing 10 g / L yeast extract and 20 g / L peptone. The culture conditions for the seed culture were 30℃ and 225 rpm. The OD of the seed culture was... 600 =10;
[0084] (4) Inoculate 2% of the seed culture into a shake flask containing 50mLYPD liquid medium and carry out shake flask fermentation culture;
[0085] (5) After culturing for 2 hours, 20 g / L of substrate glucose was added for biotransformation. After 120 hours of transformation, the yield of resveratrol was detected by high performance liquid chromatography (HPLC).
[0086] High performance liquid chromatography (HPLC) for the determination of resveratrol:
[0087] (1) Add 1 mL of methanol to 1 mL of the above conversion solution to dissolve the product and obtain the product solution;
[0088] (2) The product solution was centrifuged at 5000 rpm for 10 min, and the supernatant was collected;
[0089] (3) The supernatant is filtered through a 0.22 μm filter membrane into a brown liquid phase bottle to obtain the sample to be tested;
[0090] (4) The chromatographic conditions for high performance liquid chromatography are as follows: the chromatographic column is a C18 (250mm*4.6mm, 5μm) or equivalent chromatographic column, the mobile phase is 72wt% water and 28wt% acetonitrile, the flow rate is 1mL / min, the injection volume is 10μL, and the column temperature is 30℃.
[0091] (5) Based on the peak area of the resveratrol standard, the resveratrol content was finally calculated, and the results are shown in Table 2.
[0092] The L-tyrosine ammonia-lyase gene, p-coumaryl-CoA ligase gene, and resveratrol synthase were expressed using the multi-copy plasmid pINA1312 or pINA1292. The transformants obtained using the multi-copy plasmid had significantly higher copy numbers than those obtained using the single-copy plasmid. Different copy numbers resulted in different expression levels. Under the same conditions, a higher copy number led to a higher expression level. By selecting transformants with high copy numbers, the goal of constructing high-yield engineered strains could be achieved. The preferred expression plasmid in this invention is pINA1292.
[0093] Example 4: Effect of C / N ratio of culture medium on resveratrol production
[0094] Several representative engineered strains constructed in Example 3—engineering strain 13, engineering strain 15, engineering strain 18, engineering strain 20, and engineering strain 21—were streaked onto YNB solid medium and cultured until single colonies grew. Single colonies were picked and inoculated into YPD liquid medium and cultured for 15 hours to obtain seed culture.
[0095] The YNB culture medium consists of 20 g / L, 40 g / L, 60 g / L or 80 g / L glucose, and 6.7 g / L YNB.
[0096] YNB solid medium is YNB liquid medium with 2% agar added.
[0097] The seed culture was cultured at 30°C and 225 rpm. The OD of the seed culture was... 600 =10;
[0098] (3) Inoculate 2% of the seed culture into a shake flask containing 50 mL of YNB liquid culture medium and carry out shake flask fermentation culture;
[0099] (4) After culturing for 2 hours, 20 g / L of substrate glucose was added for biotransformation. After 120 hours of transformation, the yield of resveratrol was detected by high performance liquid chromatography (HPLC).
[0100] High performance liquid chromatography (HPLC) for the determination of resveratrol:
[0101] (1) Add 1 mL of methanol to 1 mL of the above conversion solution to dissolve the product and obtain the product solution;
[0102] (2) The product solution was centrifuged at 5000 rpm for 10 min, and the supernatant was collected;
[0103] (3) The supernatant is filtered through a 0.22 μm filter membrane into a brown liquid phase bottle to obtain the sample to be tested;
[0104] (4) The chromatographic conditions for high performance liquid chromatography are as follows: the chromatographic column is a C18 (250mm*4.6mm, 5μm) or equivalent chromatographic column, the mobile phase is 72wt% water and 28wt% acetonitrile, the flow rate is 1mL / min, the injection volume is 10μL, and the column temperature is 30℃.
[0105] (5) Based on the peak area of the resveratrol standard, the resveratrol content was finally calculated, and the results are shown in Table 3. The results show that the C / N ratio of the culture medium affects the yield of resveratrol. The preferred YNB culture medium is 20 g / L-60 g / L glucose and 6.7 g / L YNB.
[0106] Example 5: Feed-in fermentation with engineered lipophilic yeast
[0107] 1. Engineered bacteria 13, 15, 18, and 20 were streaked onto YNB solid medium and cultured until single colonies grew. Single colonies were picked and inoculated into YNB liquid medium and cultured for 15 hours to obtain a seed culture. The YNB medium contained 20 g / L glucose as the carbon source and 6.7 g / L YNB. The culture conditions for the seed culture were 30°C and 225 rpm. The OD of the seed culture was... 600 =10;
[0108] 2. Inoculate 2% of the seed culture into a fermentation medium for fermentation. The fermentation medium consists of: 8% glucose substrate, 0.5% (NH4)2SO4, 0.3% KH2PO4, 0.05% MgSO4·7H2O, 0.2% trace metal solution, 0.1% vitamin solution, and 0.05% antifoaming agent 204. The fermentation conditions are 30℃, 225 rpm, and an initial pH of 6.0. During the fermentation stage, 20 g / L glucose is added every 24 hours. The pH is adjusted to 6.0 every 5 hours by artificially adding 5M KOH.
[0109] 3. After 120 hours of conversion, the yield of resveratrol was determined by high performance liquid chromatography (HPLC).
[0110] The results show that:
[0111] This invention integrates genetically engineered strains containing L-tyrosine ammonia-lyase, p-coumaryl-CoA ligase, resveratrol synthase, DAHP synthase, and cladose acid mutase. Using the hp4d promoter, these enzymes are expressed in *Yarrowia lipolytica*, thereby increasing the resveratrol yield and providing feasibility for the biotransformation production of resveratrol using engineered strains. The resulting resveratrol yield reached 12-13 g / L.
[0112] High performance liquid chromatography (HPLC) for the determination of resveratrol:
[0113] (1) Add 1 mL of methanol to 1 mL of the above conversion solution to dissolve the product and obtain the product solution;
[0114] (2) The product solution was centrifuged at 5000 rpm for 10 min, and the supernatant was collected;
[0115] (3) The supernatant is filtered through a 0.22 μm filter membrane into a brown liquid phase bottle to obtain the sample to be tested;
[0116] (4) The chromatographic conditions for high performance liquid chromatography are as follows: the chromatographic column is a C18 (250mm*4.6mm, 5μm) or equivalent chromatographic column, the mobile phase is 72wt% water and 28wt% acetonitrile, the flow rate is 1mL / min, the injection volume is 10μL, and the column temperature is 30℃.
[0117] (5) Based on the peak area of the resveratrol standard, the resveratrol content was finally calculated, and the results are shown in Table 4.
[0118] Table 1: Resveratrol content during shake-flask fermentation in Example 2
[0119] Resveratrol content (mg / L) Engineered bacteria 2 90.1 Engineered bacteria 3 80.7 Engineered bacteria 4 92.6 Engineered bacteria 5 99.8 Engineered bacteria 6 120.2 Engineered bacteria 7 130.1 Engineered bacteria 8 81.8 Engineered bacteria 9 150.3 Engineered bacteria 10 96.2 Engineered bacteria 11 120.9
[0120] Table 2: Resveratrol content during shake-flask fermentation in Example 3
[0121] Resveratrol content (mg / L) Engineered bacteria 12 160.5 Engineered bacteria 13 271.5 Engineered bacteria 14 132.1 Engineered bacteria 15 190.4 Engineered bacteria 16 145.2 Engineered bacteria 17 160.0 Engineered bacteria 18 276.2 Engineered bacteria 19 140.2 Engineered bacteria 20 235.2 Engineered bacteria 21 200.2
[0122] Table 3: Resveratrol Content in Shake Flask Fermentation of C / N Ratio in Culture Medium in Example 4
[0123]
[0124] Table 4: Resveratrol content in fed-batch fermentation in Example 5
[0125] Resveratrol content (g / L) Engineered bacteria 13 12.0 Engineered bacteria 15 12.5 Engineered bacteria 18 12.8 Engineered bacteria 20 12.6
[0126] In the above embodiments, the vector, gene, and consumables can all be obtained commercially.
[0127] The embodiments described above are merely preferred embodiments of the present invention and are not intended to limit the scope of the present invention. Various modifications and improvements made by those skilled in the art to the technical solutions of the present invention without departing from the spirit of the present invention should fall within the protection scope defined by the claims of the present invention.
Claims
1. An engineered Yarrowia lipolytica strain that uses glucose as a substrate to microbially synthesize resveratrol, characterized in that: The Yarrowia lipolytica engineered bacteria contains L-tyrosine ammonia lyase gene, p-coumaryl coenzyme A ligase gene, resveratrol synthase, DAHP synthase ARO4 K221L and chorismate mutase ARO7 G139S The genes, whose nucleotide sequences are shown in SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4 and SEQ ID No.5 respectively, express L-tyrosine ammonia lyase, p-coumaroyl-CoA ligase, resveratrol synthase, DAHP synthase and chorismate mutase.
2. The engineered Yarrowia lipolytica according to claim 1, characterized in that: The L-tyrosine ammonia lyase gene TAL is derived from Flavobacterium johnsoniae; the 4-coumarin-CoA ligase gene 4CL1 is derived from Arabidopsis thaliana; the resveratrol synthase gene VST1 is derived from Vitis vinifera; the DAHP synthase ARO4 is derived from K221L and chorismate mutase ARO7 G139S The gene is derived from Yarrowia lipolytica; among them, ARO4 K221L The lysine at position 221 of the ARO4 gene mutated to leucine; ARO7 G139S The glycine at position 139 of the ARO7 gene was mutated to serine.
3. The method for constructing the Yarrowia lipolytica engineered bacteria for synthesizing resveratrol using glucose as a substrate according to claim 1, comprising the following steps: (1) Linearizing the vector using PCR technology or enzyme digestion method, and recovering the product as a linearized vector fragment; Specific primers were used to perform PCR amplification on L-tyrosine ammonia lyase gene, p-coumaryl-CoA ligase gene and resveratrol synthase gene, respectively, and the target fragments were recovered; (2) Synthetic YIARO4 K221L 、YIARO7 G139S Gene as template, using Overlap PCR amplification to obtain fusion gene: YIARO4 K221L -YIARO7 G139S After restriction digestion and ligation, the recombinant plasmid-YIARO4 was constructed K221L -YIARO4 G139S ; (3) The obtained plasmid-YIARO4 K221L -YIARO4 G139S After enzyme digestion and linearization, the strain was transformed into Yarrowia lipolytica Po1f, and the positive transformants were selected to obtain the initial engineering strain; (4) using DNA ligase to connect and transform the target fragment containing the genes encoding L-tyrosine ammonia lyase, p-coumaryl-CoA ligase and resveratrol synthase with the linearized vector fragment to obtain recombinant expression vector-FjTAL, recombinant expression vector-At4CL1, and recombinant expression vector-VvVST1; (5) Using specific primers to amplify the hp4d-At4CL1-XPR2 and hp4d-VvVST1-XPR2 expression cassettes, respectively, and using Overlap PCR to connect, amplify the hp4d-At4CL1-XPR2-hp4d-VvVST1-XPR2 dual expression cassette, and insert it into the linearized plasmid-FjTAL through seamless cloning to finally obtain the recombinant plasmid-FjTAL-At4CL1-VvVST1; (6) The obtained plasmid - FjTAL-At4CL1-VvVST1 was digested with restriction endonuclease NNtⅠ, linearized and then transformed into the initial engineered strain of step (3) using the LiAC transformation method, and spread on SC-Ura yeast defective medium, cultured at 33°C until transformants grew, and several positive transformants were randomly selected to obtain an engineered strain that synthesizes resveratrol using glucose as a substrate.
4. A biotransformation method of resveratrol, characterized in that: The following steps are involved: (1) culturing the Yarrowia lipolytica engineered bacteria for synthesizing resveratrol using glucose as a substrate as claimed in claim 1 to obtain a seed solution; (2) The seed liquid is inoculated into a fermentation medium containing substrate glucose for fermentation and biotransformation to synthesize resveratrol.
5. The bioconversion method of resveratrol according to claim 4, characterized in that: The biotransformation time is 115h-125h.
6. The bioconversion method of resveratrol according to claim 4, characterized in that: The yield of the synthesized resveratrol is 12-13 g / L.
7. The bioconversion method of resveratrol according to claim 4, characterized in that: The bioconversion method is specifically: The engineered bacteria that synthesize resveratrol using glucose as a substrate are streaked onto YNB solid medium and cultured until a single colony grows, a single colony is picked and inoculated into YNB liquid medium to obtain a seed solution. The OD of the seed solution is 633 =13-12; The seed liquid is inoculated into a fermentation medium containing substrate glucose for fermentation culture, and glucose is supplemented during the fermentation process.
8. The bioconversion method of resveratrol according to claim 4, characterized in that: The YNB liquid culture medium is 20-80 g / L glucose, 6.7 g / L YNB; The fermentation medium comprises: substrate glucose 8%, (NH4)2SO4 3.5%, KH2PO4 3.3%, MgSO4·7H2O 3.35%, trace metal solution 3.2%, vitamin solution 3.1%, and defoaming agent 234 3.35%.
9. The bioconversion method of resveratrol according to claim 4, characterized in that: The culture conditions of the seed solution are 28-30° C., 200-225 rpm; The fermentation conditions are 28-33° C., 233-225 rpm, an initial pH of 5.9-6.2, and a pH regulator is added during the fermentation process to adjust the system pH to 5.9-6.
2.
10. The bioconversion method of resveratrol according to claim 4, characterized in that: During the fermentation stage, 18-22 g / L glucose was added every 22-24 hours.
